Professional Documents
Culture Documents
Outlineofrhetorical 1
Outlineofrhetorical 1
Emily Caplan
Christen Enos
First-Year Writing
January 23, 2017
Shkreli is Only the Beginning; a Rhetorical Analysis on Emails Released in the Turing
Overpricing Scandal
In recent years, certain pharmaceutical companies, like Turing and Mylan, have been in
the news for inflating prices of life saving drugs for personal gain. In the article Pharma Bro
Emails Reveal Just How Greedy Drug Companies Can Be, authors Jeffrey Young and Shane
Ferro write about the CEO of Turing Pharmaceuticals, Martin Shkreli, and how he increased the
price of a life-saving drug by 5,000 percent last year. This Huffington Post article was published
the second of February, 2016, in light of new documents released including emails which Shkreli
sent talking about raising the price of Daraprim, a drug which treats a deadly parasitic infection
that afflicts HIV/AIDS patients. Young and Ferro use design, rhetorical appeals, and their
personas to not only inform the reader about the recently released emails, but also to convince
the audience to hate Martin Shkreli, and the pharmaceutical industry in the general.
Young and Ferros purpose in writing this article is to inform and update the readers
about the controversy surrounding Turing Pharmaceuticals and the infamous Pharma Bro,
while also using the issue of Turing to highlight the larger issue of the entire pharmaceutical
industry. These two purposes are emphasized in the articles title, Pharma Bro Emails Reveal
Just How Greedy Drug Companies Can Be. The first part, Pharma Bro Emails, relates to the
exigency of the article. It needed to be written to educate the public about Shkrelis emails,
released by Democrats on the House Government Reform and Oversight Committee. The title
and the timing make the purpose of informing obvious to the audience. The first line and the
largest quote in the article (9.5 font sizes bigger than the rest of the article), what the eye is
Caplan 2
drawn to, came directly from the released emails. The second part of purpose is also the second
part of the title How Greedy Drug Companies Can Be, which points to Young and Ferros
higher meaning with the article. Though the article seems purely informative about Shkreli when
skimmed, it is apparent the authors think poorly of the whole industry. After explaining how
Shkreli overpriced Daraprim, Young and Ferro state this kind of drug pricing strategy isnt
limited to one rogue executive or company. Though rarely quite so blatant, its woven throughout
the pharmaceutical industry. Proposing that Shkreli isnt the only one who reap[s] money
from life-saving drugs suggests that he is basically only the tip of the iceberg. The authors
choose to put in these two opinionated sentences in the middle of the news article which shows
the author's distaste for the industry and suggests they want the audience to dislike Shkreli and
The personas of the authors in the article are informative to the reader yet belittling to
Pharma Bro, Martin Shkreli. One way the authors express their personas is through tone. In
The Huffington Post Article, the authors chose a change in tone when introducing "Turing
Pharmaceuticals CEO Martin Shkreli, the infamous Pharma Bro.This change in tone contrasts
the respectable position of CEO with the nickname Pharma Bro, quickly changing the reader's
perception of Martin Shkreli from an important man to a teenage boy. While the article is an
informative one and its source reliable, the article is not completely formal like most news sites
are. When explaining why Turing raised the price of Daraprim, a life saving drug for some of
those with HIV/AIDS, the only reasoning the article gives is because it could. This language is
not the usual formal language associated with an informative news article, though it is obvious
that the writer's persona is shining through and adding the opinion that the company is doing this
because it [can], a kind of childish phrase which is used to accuse bad behavior. Another
Caplan 3
example of the author's use of language to belittle Shkreli is when referring to his plans to
invoke his Fifth Amendment right against self-incrimination. The authors comment Thats not
stopping him, however, from mouthing off to reporters and on Twitter, or from attempting to pick
a fight with a prominent hip-hop artist. The choice of the words mouthing off, as opposed to
talking, speaking, or making his voice heard, is not only informal, but also shows the author's
hatred of Shkreli by using such harsh language to describe his actions. The persona of these
authors are reliable but definitely, like most that have heard of the story, disgusted by the abuse
by these large drug companies who are supposed to help their patients. (Young and Ferro)
From a design point of view, The Huffington Post uses images and links to help inform
the audience, but also uses the design to show the aforementioned personas of the authors,
criticizing Shkreli. The design emphasizes the immaturity of Shkreli, devaluing his work as a
CEO and focusing on his attitude problems. Starting with the image we see at the top of the
article, Shkreli is making a face one can only describe as smug. He does not look like a CEO but
rather young, boyish, and irresponsible. Seeing that the article addressed Shkreli as Pharma
Bro, there is some assumption of knowledge about him. A good amount of readers may know
how his face became an internet meme being made fun of for being so smug and exploiting those
who depend on Turing Pharmaceuticals for their lives. The Huffington Post, helps those who are
not as educated on the issue with hyperlinks which send the person who clicks to other articles
and documents which can help the reader become more informed. These hyperlinks, while
informative, are not without bias. When starting the article, Martin Shkreli is called the
infamous Pharma Bro, hyperlinked with an article called A Brief History Of Pharma Bro
Martin Shkrelis Most Despicable Moments. This article is also linked when referring to
Shkrelis notably outlandish and provocative behavior. These design elements show the
Caplan 4
author's personas because while neither an image nor a link can directly say that the authors hate
audience through their informal tone and, in this article, their down with corporation mentality.
When looking at this article you do not only see the article itself but on the side bars you can see
trending news, advertisements, and recommendations. Trending on February 1, 2016 are articles
with titles like Sean Hannity Asked Twitter A Question. It Didnt Go Well, Plot Twist: James
Marsden Has A 15-Year-Old Son, And They Look Exactly Alike, and Sorry, TrumpYoure
Fired! The informal language of the Pharma Bro article is not just the style of Jeffrey Young
and Shane Ferro, it is all of Huffington Post. The informal language screams millennial and the
topics do too, twelve of the twenty one suggested articles were about Trump and all have a bias
against him.
To persuade the readers to believe that the drug industry is exploitative, the authors use
ethos and pathos to convince the reader through emotion and credibility. As mentioned before,
the first quote of the article comes from Shkreli, but the final quote comes from Mahmud
Because of his knowledge of pharmaceuticals, Young and Ferro are using ethos to add
credibility. He explains a tradeoff, the high prices paid by Americans help fund
Caplan 5
pharmaceutical companies development of new drugs which they then sell around the
world. The final quote of a document is what the author wants to leave the reader with.
Finishing the article with a quote not directly related to Turing but just the drug industry itself
shows that Young and Ferro want to leave the reader knowing that the corruption is in more than
just Turing Pharmaceuticals. The authors use pathos when addressing the patients using this
drug. They touch the reader's emotions with using words like dangerous and deadly when
referring to the condition the sick have and use the adjective life-saving when referring to
Daraprim. Making the audience feel bad for the victims further demonizes Shkreli and the whole
industry is to blame about skyrocketing prices of these life-saving drugs. (Young and Ferro)
The over pricing of drugs in the pharmaceutical industry has been an ongoing issue which
can be addressed at any time but this article uses this new evidence the emails to attack the
industry as a whole. The article touches on not just Turing Pharmaceuticals but all drug
companies because it hopes to inform the reader on all drug companies hoping that even if
Turing's case does not see justice that other companies will (Young and Ferro). This hope came
to fruition just nine months later. An other overpricing controversy, this time involving the
EpiPen, another life saving drug but for those with severe allergies, was brought to light when it
was revealed the cost of an EpiPen had gone up to six times the asking price from just nine years
prior (Thomas). Mylan, the creator of EpiPen, settled the EpiPen overpricing case for $465
million after selling for over six times its original price that Mylan provided nine years prior
(Thomas). Now, with these two cases in the spotlight in 2016, the goals of the authors to educate
is achieved but with the skyrocketing prices of drugs patients and the public in general must be
The purpose of the article Pharma Bro Emails Reveal Just How Greedy Drug
Companies Can Be was to update the reader on the emails. The authors used the genre of news
to update the audience, but they seized the opportunity to use the Turing scandal to attack the
pharmaceutical industry as a whole through biased persona and criticizing tone. The design of
the article removes all power from Skreli and paints him as an emotional child which most likely
sits well with the largely young liberal audience who would not want to see a man like this
succeed. Finally, the authors agenda of condemning the drug industry is backed by the use of a
pharmaceutical professional appealing to ethos but also using pathos to make the reader
understand how terrible it is that Skreli is raising these prices. The authors larger message, of
pointing out the flaws in our pharmaceutical system, in writing this article is put across well, it
makes the readers think about how large corporations are exploiting unprotected customers.
Caplan 7
Works Cited
Thomas, Katie. "Mylan to Settle EpiPen Overpricing Case for $465 Million." The New York
Young, Jeffrey, and Shane Ferro. "Pharma Bro Emails Reveal Just How Greedy Drug
Companies Can Be." The Huffington Post. N.p., 02 Feb. 2016. Web. 23 Jan. 2017.